The 2018 assisi think tank meeting on breast cancer: International expert panel white paper
- PMID: 32450277
- DOI: 10.1016/j.critrevonc.2020.102967
The 2018 assisi think tank meeting on breast cancer: International expert panel white paper
Abstract
We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.
Keywords: Breast cancer; Breast reconstruction; De-escalating therapy; Ductal carcinoma in situ; Hypofractionation; Neoadjuvant chemotherapy; Partial breast irradiation; Post-mastectomy radiation therapy; Radiation therapy.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no conflict of interest. Doctor Charlotte Coles is supported by the National Institute of Health Research (NIHR) Research Professorship and Cambridge Biomedical Research Centre. Dr Ugur Selek is an Accuray Advisory Board.